Literature DB >> 8244457

Differential regulation of cytokine production by nitric oxide.

J Marcinkiewicz1, B M Chain.   

Abstract

Nitric oxide (NO) has recently been identified as a potent and pleiotropic intracellular mediator produced by and acting on many cells of the body. Although considerable attention has been devoted to the regulation of NO by inflammatory cytokines, and also to the role of NO as an important effector molecule in immune function, there is very little information on the role of this mediator in modulating T-cell-dependent cytokine production. In this study we show that physiological levels of NO (either produced by activated macrophages or by the addition of exogenous NO donors) can selectively down-regulate interleukin-3 (IL-3) production by spleen cells from contact-sensitized mice, while leaving IL-2 activity unaffected. Thus NO may have an important role as an immunomodulatory as well as effector molecule in the immune system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244457      PMCID: PMC1422106     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Antigen-specific inhibition of IL-2 and IL-3 production in contact sensitivity to TNP.

Authors:  J Marcinkiewicz; B Chain
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

Review 2.  Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

Review 3.  Second messenger role for NO widens to nervous and immune systems.

Authors:  J Collier; P Vallance
Journal:  Trends Pharmacol Sci       Date:  1989-11       Impact factor: 14.819

4.  Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.

Authors:  F Y Liew; S Millott; Y Li; R Lelchuk; W L Chan; H Ziltener
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

5.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine.

Authors:  R A Hoffman; J M Langrehr; T R Billiar; R D Curran; R L Simmons
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

7.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.

Authors:  M Betz; B S Fox
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

8.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

9.  S-nitroso-glutathione inhibits platelet activation in vitro and in vivo.

Authors:  M W Radomski; D D Rees; A Dutra; S Moncada
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

View more
  8 in total

1.  Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells.

Authors:  H Bauer; T Jung; D Tsikas; D O Stichtenoth; J C Frölich; C Neumann
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Staphylococcal enterotoxin A acts through nitric oxide synthase mechanisms in human peripheral blood mononuclear cells to stimulate synthesis of pyrogenic cytokines.

Authors:  S J Won; W T Huang; Y S Lai; M T Lin
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus.

Authors:  Jennifer L Szczytkowski; Christina Lebonville; Lee Hutson; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2013-01-26       Impact factor: 7.217

4.  The involvement of nitric oxide in a mouse model of adult respiratory distress syndrome.

Authors:  L H Pheng; C Francoeur; M Denis
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

5.  Endotoxin-induced desensitization of mouse macrophages is mediated in part by nitric oxide production.

Authors:  H Fahmi; D Charon; M Mondange; R Chaby
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

6.  Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge.

Authors:  Cheol-Su Kim; Hai-Duong Nguyen; Rosa Mistica Ignacio; Jae-Hyun Kim; Hyeon-Cheol Cho; Eun Ho Maeng; Yu-Ri Kim; Meyoung-Kon Kim; Bae-Keun Park; Soo-Ki Kim
Journal:  Int J Nanomedicine       Date:  2014-12-15

7.  Control of Orthodontic Tooth Movement by Nitric Oxide Releasing Nanoparticles in Sprague-Dawley Rats.

Authors:  Derrick Crawford; Tommy C Lau; Megan C Frost; Nan E Hatch
Journal:  Front Dent Med       Date:  2022-04-14

8.  Modulation of nitric oxide synthase activity in macrophages.

Authors:  P G Jorens; K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.